Novo Nordisk selects first drug candidate in Dicerna collaboration
Danish Novo Nordisk has selected its first drug candidate for the collaboration with Dicerna.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Danish pharmaceutical giant Novo Nordisk has nominated its first drug candidate for the firm's collaboration with US pharmaceutical firm Dicerna, according to Danish business media Finans' information on the basis of a Dicerna press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
